$0.21

-0.75 (-78.12%)

Weekly Expected Move ±358.9%

$-1 $-1 $0 $1 $2

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 48 · $2.8M mcap · 11M float · 0.044% daily turnover · Short 12% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Income Trends

Revenue

$317M +84.6% ▲

5Y CAGR: +6.0%

Gross Profit

$222M +71.4% ▲

5Y CAGR: +4.3%

Operating Income

$81M +2823.8% ▲

5Y CAGR: +1.8%

Net Income

$36M +513.1% ▲

5Y CAGR: -7.3%

EPS (Diluted)

$2.73 +513.6% ▲

5Y CAGR: -3.5%

EBITDA

$78M +9050.2% ▲

5Y CAGR: -0.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2018	FY2019	FY2020	FY2021	FY2022
Revenue	$213M	$196M	$188M	$172M	$317M
YoY Growth	-9.9%	-8.2%	-4.1%	-8.7%	+84.6%
Cost of Revenue	$62M	$61M	$45M	$42M	$95M
Gross Profit	$151M	$135M	$142M	$129M	$222M
Gross Margin	71.0%	68.9%	75.8%	75.4%	70.0%
R&D Expenses	$44M	$37M	$31M	$51M	$34M
SG&A Expenses	$61M	$76M	$79M	$75M	$107M
Operating Expenses	$105M	$113M	$109M	$127M	$141M
Operating Income	$37M	$22M	$33M	$3M	$81M
Operating Margin	17.2%	11.1%	17.5%	1.6%	25.6%
Interest Expense	$3M	$3M	$3M	$2M	$4M
Income Before Tax	$34M	$22M	$23M	-$5M	$61M
Tax Expense	$2M	$8M	$11M	$4M	$26M
Net Income	$32M	$14M	$12M	-$9M	$36M
Net Margin	15.0%	7.3%	6.4%	-5.0%	11.3%
EPS (Diluted)	$2.09	$1.01	$0.87	$-0.66	$2.73
EBITDA	$40M	$29M	$30M	$847K	$78M
Shares Outstanding	15M	14M	14M	13M	13M

Line Item	FY2021 Q3	FY2021 Q4	FY2022 Q1	FY2022 Q2	FY2022 Q3	FY2022 Q4	FY2023 Q1	FY2023 Q2
Revenue	$40M	$42M	$116M	$74M	$66M	$61M	$66M	$65M
Cost of Revenue	$8M	$12M	$28M	$24M	$24M	$20M	$17M	$17M
Gross Profit	$32M	$30M	$88M	$50M	$42M	$41M	$49M	$48M
Gross Margin	79.3%	70.9%	76.0%	68.1%	64.1%	67.3%	73.9%	73.9%
R&D Expenses	$23M	$4M	$6M	$11M	$9M	$7M	$9M	$10M
SG&A Expenses	$18M	$20M	$22M	$37M	$23M	$24M	$28M	$28M
Operating Expenses	$42M	$24M	$28M	$48M	$33M	$31M	$37M	$37M
Operating Income	-$10M	$6M	$60M	$2M	-$2M	$9M	$6M	$10M
Operating Margin	-25.5%	13.9%	51.6%	3.0%	-3.5%	15.6%	9.3%	15.9%
Interest Expense	$396K	$395K	$366K	$552K	$2M	$2M	$2M	$1M
Income Before Tax	-$13M	$1M	$58M	-$6M	-$45K	$13M	$10M	$9M
Tax Expense	-$7M	$7M	$14M	$4M	$3M	$5M	$4M	$4M
Net Income	-$6M	-$6M	$44M	-$9M	-$4M	$8M	$6M	$5M
Net Margin	-14.1%	-14.6%	38.0%	-12.7%	-5.3%	13.5%	8.7%	8.0%
EPS (Diluted)	$-0.43	$-0.48	$3.41	$-0.74	$-0.27	$0.62	$0.44	$0.39
EBITDA	-$10M	$3M	$59M	$2M	$2M	$21M	$17M	$16M
Shares Outstanding	13M	13M	13M	13M	13M	13M	13M	13M

EGRX OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet